This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Feb 25;137(8):1004-1006.

doi: 10.1182/blood.2020009406.

CAR-T treatment of pediatric AML: a long and winding road

Barbara De Moerloose¹

Affiliations

PMID: 33630051
DOI: 10.1182/blood.2020009406

Free article

Comment

CAR-T treatment of pediatric AML: a long and winding road

Barbara De Moerloose. Blood. 2021.

Free article

. 2021 Feb 25;137(8):1004-1006.

doi: 10.1182/blood.2020009406.

Author

Barbara De Moerloose¹

Affiliation

¹ Ghent University Hospital.

PMID: 33630051
DOI: 10.1182/blood.2020009406

No abstract available

PubMed Disclaimer

Comment on

CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy.
Willier S, Rothämel P, Hastreiter M, Wilhelm J, Stenger D, Blaeschke F, Rohlfs M, Kaeuferle T, Schmid I, Albert MH, Binder V, Subklewe M, Klein C, Feuchtinger T. Willier S, et al. Blood. 2021 Feb 25;137(8):1037-1049. doi: 10.1182/blood.2020006921. Blood. 2021. PMID: 33094319

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information